研究業績

2024

• 13.

  2024

  Yamamoto, T. Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: interim analysis of a post-marketing observational study in Japan, The journal of dermatology, accepted.

• 12.

  2024

  Nakanishi, T. Amelioration of Systemic Amyloidosis by Blocking IL-17A and not by IL-17F, and Arteriosclerosis by Blocking both IL-17A and IL-17F in Inflammatory Skin mouse model. The International Journal of Molecular Sciences, accepted.

• 11.

  2024

  Sakashita, C. A case of Stevens-Johnson Syndrome after Influenza A Virus Infection, Journal of Dermatology, accepted.

• 10.

  2024

  Matsuura, Y. Lichen planus pemphigoides treated with a low dose of oral prednisolone and omalizumab. JAAD Case Reports, accepted.

• 9.

  2024

  Kondo, M. Changes in skin bacterial flora during the healing process of ulcer caused by self-destruction of lymph nodes due to tuberculous lymphadenitis. The Journal of Dermatology, accepted.

• 8.

  2024

  Mizutani, Y. Neonatal Lupus Erythematosus with Histopathological Presentation of Interstitial Granulomatous Dermatitis. International Journal of Dermatology, accepted.

• 7.

  2024

  Tada, Y. Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study, The journal of dermatology, accepted.

• 6.

  2024

  Sugiura, K. Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a post-marketing surveillance study. The Journal of Dermatology, accepted.

• 5.

  2024

  Mizutani, Y. Pityriasis Lichenoides et Varioliformis Acuta Developing during Pembrolizumab Treatment for Bladder Cancer. Case Reports in Dermatology, accepted.

• 4.

  2024

  Kondo, M. Dermoscopic image of the hairs in a very early lesion of tinea capitis caused by Trichophyton rubrum, Clinical Case Reports, accepted.

• 3.

  2024

  Sugiura, K. The Role of Interleukin-36 in Health and Disease States, The Journal of the European Academy of Dermatology and Venereology, accepted.

• 2.

  2024

  Kitano, D. Intra-soft tissue and intramedullary antibiotic perfusion in combination with negative pressure wound therapy. Journal of Wound Care, 32 (Sup 11) on line. https://doi.org/10.12968/jowc.2023.32.Sup11.S14

• 1.

  2024

  Nishimura, M. Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption, Int J Mol Sci. accepted.

2023

• 23.

  2023

  Kondo, M. A case of Japanese spotted fever probably transmitted by a tick bite caused by Haemaphysalis cornigera, The journal of Dermatology, accepted.

• 22.

  2023

  Kondo, M. Surveying tick-borne pathogen antibodies in a high-risk area for Japanese spotted fever, International Journal of Dermatology, accepted.

• 21.

  2023

  Yamanaka, K. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review. The journal of Dermatology, accepted.

• 20.

  2023

  Sugioka, K. Elephantiasis verrucous lesions on psoriatic plaque improved with anti-IL-23p19 antibody therapy. The Journal of Dermatology, accepted.

• 19.

  2023

  Yamamoto, T. Clinical guidance of pyoderma gangrenosum, J Dermatology 50 (9), 253, 2023

• 18.

  2023

  Mori, T. Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients. Frontiers in Medicine DOI 10.3389/fmed.2023.1229937.

• 17.

  2023

  Tada, Y. Real-world retention rates and effectiveness of secukinumab in psoriasis: results from a multicenter cohort study (RAILWAY), The Journal of Dermatology, accepted.

• 16.

  2023

  Nakanishi, M. A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination, Journal of Dermatology, accepted.

• 15.

  2023

  Kitagawa H, Partial excision and ablative carbon dioxide fractional laser therapy for multiple apocrine hidrocystomas on the periorbital regions and cheeks, Case Reports in Dermatological Medicine, accepted.

• 14.

  2023

  Kondo, M. Consideration of serum IL-36α and β levels trends in two patients with chikungunya fever, Clinical Case Reports, accepted.

• 13.

  2023

  Sakashita, C. Exacerbation of generalized pustular psoriasis after administration of granulocyte colony-stimulating factor in a patient with intravascular large B-cell lymphoma, The Journal of Dermatology, accepted.

• 12.

  2023

  Kondo, M. A case of pyoderma gangrenosum around the urethral meatus aggravated by COVID-19 infection and further worsened due to the development of pyogenic osteomyelitis 8 years after urostomy, Clinical Case Reports, accepted.

• 11.

  2023

  Yokota, N. Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well-controlled by mepolizumab treatment. Clinical Case Reports, accepted.

• 10.

  2023

  Iida, S. Inflammatory skin disease causes anxiety symptoms leading to an irreversible course. Int J Mol Sci. accepted.

• 9.

  2023

  Nakanishi, T. Arteriosclerosis derived from cutaneous inflammation is ameliorated by the deletion of IL-17A and IL-17F. International Journal of Molecular Sciences, accepted.

• 8.

  2023

  Kondo, M. Epstein–Barr virus DNA measurement in skin tumor lesions might be a sensitive diagnostic marker of recurrence in patients with nasal-type extranodal NK/T-cell lymphoma: a case report, The Journal of Dermatology, accepted.

• 7.

  2023

  Kondo, M. Seborrheic keratosis caused by Human papillomavirus type 20 ameliorated by zinc oxide ointment, Clinics and Practice, accepted.

• 6.

  2023

  Sugioka, K. Pachydermoperiostosis complicated with psoriatic arthritis successfully treated with an anti-IL-17A antibody, JAAD Case Reports, accepted.

• 5.

  2023

  Nakanishi, M. Diagnostic utility of TUNEL staining for degenerative keratoacanthoma requiring histopathologic differentiation from seborrheic keratosis. Case Reports in Dermatology, accepted.

• 4.

  2023

  Yamanaka, K. The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis, International Journal of Molecular Sciences, accepted.

• 3.

  2023

  Kondo, M. Increasing risk of tick-borne disease through growth stages in ticks, Clinics and Practice, accepted.

• 2.

  2023

  Akeda, T. Treatment strategy in patients with psoriatic disease and rheumatoid arthritis, Clinics and Practice, accepted, 2023

• 1.

  2023

  Morita, A. Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study. JEADV Clinical Practice, accepted, 2023

2022

• 25.

  2022

  Nakamura, Y. Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients, European Journal of Cancer 176, 78-87, 2022.

• 24.

  2022

  Kondo, M. Epidemiological study of ticks harboring Aeromonas hydrophila in areas endemic and non-endemic to Japanese spotted fever, Tropical Medicine & International Health, accepted

• 23.

  2022

  Nishimura M. Treatment strategy for pyoderma gangrenosum: skin grafting with immunosuppressive drugs, Journal of Clinical Medicine, accepted.

• 22.

  2022

  Yamanaka, K. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study, J Dermatology, accepted.

• 21.

  2022

  Yamawaki, M. Bullous pemphigoid in X-linked Alport syndrome: A case report. Internal Medicine, accepted.

• 20.

  2022

  Ikejiri, K. Septic pulmonary embolism and subsequent bilateral pneumothorax in patients undergoing chemoradiotherapy for head angiosarcoma: An autopsy case report and literature review. Medicine®, accepted.

• 19.

  2022

  Kondo, M. Detection of Cutibacterium acnes from Multiple miliary osteoma cutis., Clinical Case Reports, accepted.

• 18.

  2022

  Nishimura, M. Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris, Clinical Case Reports, accepted.

• 17.

  2022

  Fujisawa, Y. Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases. Eur J Cancer. 2021 Mar;145:210-220. doi: 10.1016/j.ejca.2020.12.021. Epub 2021 Jan 24.

• 16.

  2022

  Umeda, Y. Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study. Eur J Cancer. 2021 Nov;157:361-372. doi: 10.1016/j.ejca.2021.08.034. Epub 2021 Sep 23.

• 15.

  2022

  Kondo, M. Japanese Spotted Fever and Irreversible Renal Dysfunction during Immunosuppressive Therapy after a Living-donor Kidney Transplant. Tropical Medicine and Infectious Disease, accepted.

• 14.

  2022

  Matsushima, Y. A case of IgG and IgA anti-laminin-332 antibody-positive mucous membrane pemphigoid with IgG and IgA anti-envoplakin and anti-periplakin antibodies. Dermatopathology, accepted.

• 13.

  2022

  Kasai, A. Papuloerythroderma of Ofuji associated with sternoclavicular arthritis and successful treatment with cyclosporine. JAAD Case Reports, accepted.

• 12.

  2022

  Morita, A. Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis. The Journal of Dermatology, accepted.

• 11.

  2022

  Iida, S. IL-17A is the critical cytokine for liver and spleen amyloidosis in inflammatory skin disease. International Journal of Molecular Sciences, accepted.

• 10.

  2022

  Goto, H. Psoriasis-like skin lesions occurring at remote sites after topical imiquimod, The Journal of Dermatology, accepted.

• 9.

  2022

  Ueki-Mizuno, A. A case of papuloerythroderma successfully treated with dupilumab, Case Reports in Dermatology Switzerland, accepted.

• 8.

  2022

  Nishimura, M. A case of adult-onset eccrine angiomatous hamartoma-the comparison with epithelioid hemangioma, Dermatopathology, accepted.

• 7.

  2022

  Ida, M. Subtle-but-smoldering Myocardial Injury After Immune Checkpoint Inhibitor Treatment Accompanied by Amyloid Deposits. ESC Hear Failure, accepted.

• 6.

  2022

  Kondo, M. A novel transmission of Aeromonas hydrophila via tick bites. The Journal of Dermatology, accepted.

• 5.

  2022

  Kondo, M. Investigation of pathogens injected into the human body by ticks. Experimental Dermatology, accepted.

• 4.

  2022

  Yamasaki, K. Adalimumab in Japanese Patients with Active Ulcers of Pyoderma Gangrenosum: Final Analysis of a 52-Week Phase 3 Open-label Study. The Journal of Dermatology, accepted.

• 3.

  2022

  Matsushima, Y. Severe skin inflammation leads to salivary gland atrophy and dysfunction. The Journal of Dermatology, accepted.

• 2.

  2022

  Tsunoda, A. Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer. Case Reports in Oncological Medicine, accepted.

• 1.

  2022

  Watanabe, S. Eosinophilic fasciitis induced by a game of drumming probably via type2 innate immunity. International Journal of Rheumatic Diseases, accepted.

2021

• 21.

  2021

  Nakamura, Y. Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study).ESMO Open. 2021 Dec;6(6):100325. doi: 10.1016/j.esmoop.2021.100325. Epub 2021 Nov 25.PMID: 34839104

• 20.

  2021

  Saiki, H. A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues.Cells.2021 Oct 26;10(11):2885.doi: 10.3390/cells10112885.

• 19.

  2021

  Nakai, Y. Progressive vitiligo induced by recurrent melanoma. Clinical Case Reports, accepted.

• 18.

  2021

  Nakanishi, T. Janus kinase inhibitors ameliorated gastrointestinal amyloidosis and hypoalbuminemia in persistent dermatitis mouse model. International Journal of Molecular Sciences, accepted.

• 17.

  2021

  Yamanaka, K. Special Issue: “Skin Disease and Comorbidities”. Journal of Clinical Medicine, 2021, 10, 5754.

• 16.

  2021

  Kondo, M. Possible HSP reactivation post COVID-19 vaccination and booster. Clinical Case Reports, accepted.

• 15.

  2021

  Kondo, M. Alternation of the cutaneous microbiome of herpes zoster lesion in a patient with severe coronavirus disease 2019. International Journal of Dermatology, accepted.

• 14.

  2021

  Kondo, M. The presence of Tularemia infection in patients with Japanese spotted fever. J Dermatol. 2021 Aug;48(8):1277-1280. doi: 10.1111/1346-8138.15934. Epub 2021 May 5.

• 13.

  2021

  Goto, H. Successful treatment of ulcerative-type pyoderma gangrenosum with a combination therapy of oral prednisolone, vacuum-assisted closure, and skin grafting. Case Reports in Dermatology, accepted.

• 12.

  2021

  Nakanishi, T. Reduction in Tumor Lesions and Exacerbation of Psoriatic Rash after Septic Shock in a Patient with Extramammary Paget’s Disease. Case Reports in Oncology, accepted.

• 11.

  2021

  Kondo, M. Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: a case report with detailed laboratory data. Clinical Case Reports, accepted.

• 10.

  2021

  Nakayama, Y. Whether to maintain or strengthen the treatment for pyoderma gangrenosum ulcerative type may depend on the response after two to four-week treatment intervention: the outcome of three cases with details clinical course. Clinical Case Reports, accepted.

• 9.

  2021

  Kondo, M. Subcutaneous Aspergillus nodule with cutaneous Enterococcus infection.Oxford Medical Case Reports, accepted.

• 8.

  2021

  Habe, K. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease. Clin Rheumatol. 2021 Jun 16. doi: 10.1007/s10067-021-05781-w. Online ahead of print.

• 7.

  2021

  Kondo, M. A case of α-gal unrelated red meat induced urticaria treated by omalizumab. Case Reports in Dermatology, accepted.

• 6.

  2021

  Yamanaka, K. Psoriatic Transversal Nail grooves on Biologics. Clinical Case Reports, accepted.

• 5.

  2021

  Kondo, M. Lymphocyte transformation test: the multiple positive results turned to all negative after influenza infection. Clinical Case Reports, accepted.

• 4.

  2021

  Sugioka, K. Three cases of lymphocytic infiltration of the eyelid. Dermatopathology (Basel). 2021 May 8;8(2):124-129. doi: 10.3390/dermatopathology8020018.

• 3.

  2021

  Kondo, M. Dominance of methicillin resistant Staphylococcus aureus in a Japanese infant with recessive dystrophic epidermolysis bullosa. Case Reports in Dermatology, 2021 Jun 8;13(2):278-281. doi: 10.1159/000516354.

• 2.

  2021

  Yamanaka, K. Pathophysiology of psoriasis: A review. J Dermatol, 2021 May 21. doi: 10.1111/1346-8138.15963.

• 1.

  2021

  Kondo, M. Immunoglobulin G levels against Staphylococcus aureus maintained before and after treatment of severe atopic dermatitis. J Dermatol. 2021 Jun;48(6):e277-e278. doi: 10.1111/1346-8138.15871.

2020

• 18.

  2020

  Kondo, M. Transition of Serum Cytokine Concentration in Rickettsia japonica Infection. Infect Dis Rep. 2020 Dec 11;12(3):127-131.

• 17.

  2020

  Sugioka, K. Palisaded neutrophilic granulomatous dermatitis, interstitial granulomatous dermatitis and IgA vasculitis associated with incomplete Sjögren’s syndrome. J Dermatol, accepted.

• 16.

  2020

  Iida, S and Sugioka, K. Verruca vulgaris and seborrheic keratosis exacerbated by immunosuppression. Case Reports in Dermatological Medicine, 2020 Dec 2;2020:6682694.

• 15.

  2020

  Mizutani, K. Development of cutaneous squamous cell carcinoma during pembrolizumab therapy. J Dermatol. 2020 Sep 17.

• 14.

  2020

  Sawada, Y. Voriconazole-induced squamous cell carcinoma after hematopoietic stem cell transplantation showing early-stage vascular invasion. Dermatopathology, (Basel) 2020 Oct 9;7(3):48-52.

• 13.

  2020

  Masukawa, E. Two cases of cutaneous adverse effects induced by TNF-α inhibitors. Case Reports in Dermatology Switzerland, 2021 Apr 19;13(1):238-243. doi: 10.1159/000511985.

• 12.

  2020

  Arakawa, H. Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy. Allergology International. Volume 69, Issue 1, January 2020, Pages 84-90

• 11.

  2020

  Yamasaki, K. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study. Journal of Dermatology, 2020 Dec;47(12):1383-1390. Epub 2020 Aug 17.

• 10.

  2020

  Papp, K. An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician’s Global Assessment > 1 at week 12. British Journal of Dermatology Volume 183, Issue 1, 1 July 2020, Pages 52-59.

• 9.

  2020

  Matsushima, Y. Mizutani, K, Goto, H. Emaciation, congestive heart failure, and systemic amyloidosis in severe recessive dystrophic epidermolysis bullosa: possible internal complications due to skin-derived inflammatory cytokines derived from the injured skin. Dermatopathology 2020, 7(2), 41-47;

• 8.

  2020

  Ishikawa, M. A case of pruritic urticarial papules and plaques of pregnancy; pathophysiology and serum cytokine profile. Case Reports in Dermatology, accepted.

• 7.

  2020

  Umaoka, A. Skin Inflammation and Testicular Function: Dermatitis Causes Male Infertility via Skin-Derived Cytokines. Biomedicines 2020, 8(9), 293;

• 6.

  2020

  kondo, M. Case of Japanese spotted fever infected 2 consecutive years. J Dermatol. 2020 Aug;47(8):e310-e311. doi: 10.1111/1346-8138.15430. Epub 2020 Jun

• 5.

  2020

  Mizutani, K. Inflammatory Skin-Derived Cytokines Accelerate Osteoporosis in Mice with Persistent Skin Inflammation. International Journal of Molecular Sciences. 2020 May 20;21(10):3620. doi: 10.3390/ijms21103620.

• 4.

  2020

  Mizutani, K. Systemic dermatitis model mice cause atrophy of visceral adipose tissue and increase stromal cell via skin-derived inflammatory cytokines. International Journal of Molecular Sciences, 2020 May 9;21(9):3367. doi: 10.3390/ijms21093367.

• 3.

  2020

  Okada, K. The role of gut microbiome in Psoriasis: Oral administration of Staphylococcus aureus and Streptococcus danieliae exacerbates skin inflammation of imiquimod-induced psoriasis-like dermatitis. International Journal of Molecular Sciences, 2020 May 7;21(9):3303. doi: 10.3390/ijms21093303.

• 2.

  2020

  Mizutani, K. Multiple tophi and exacerbated psoriatic erythroderma. J Dermatol. 2020 Apr 30. doi: 10.1111/1346-8138.15354.

• 1.

  2020

  Kondo, M. Case of toxic epidermal necrolysis in immunocompromised patient possibly due to Streptococcus pneumoniae serotype uncovered by vaccine. J Dermatol. 2020 Apr;47(4):e106-e107.

2019

• 10.

  2019

  Papp, K. An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician’s Global Assessment > 1 at week 12. Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18550.

• 9.

  2019

  Kondo, M. Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type. Case Rep Dermatol. 2019 Jun 26;11(2):194-197.

• 8.

  2019

  Mizutani, K. Interleukin-17-dressed neutrophil: Neutrophil does not produce but delivers interleukin-17 to lesional epidermis causing keratinocyte S100A expression. Indian J Dermatol Venereol Leprol. 2019 Sep-Oct;85(5):531-534.

• 7.

  2019

  Matsushima, Y.Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab. Case Rep Dermatol. 2019 Nov 27;11(3):317-321.

• 6.

  2019

  Yajima, M. Alopecia diffusa during the use of interleukin-17 inhibitors against psoriasis vulgaris. Case Reports in Dermatolog. 2019 Mar 28;11(1):82-85.

• 5.

  2019

  Kondo, M. Case of Th2 Cytokines in a Japanese Girl Who Acquired Hookworm-Related Cutaneous Larva. Journal of Dermatology Research and Therapy, 2019, 5: 064

• 4.

  2019

  Kondo, M. Varicella zoster virus detection from the crust using by Derma QuickⓇ VZV. J Dermatol Stud Treat. 18 Dec 2018

• 3.

  2019

  Okada, K. Infantile bullous pemphigoid successfully treated with i.v. immunoglobulin and cyclosporin. J Dermatol. 2019 Jun;46(6):e213-e214.

• 2.

  2019

  Matsushima, Y. Vitamin D is no substitute for the sun. J Allergy Clin Immunol. 2019 Mar;143(3):929-931.

• 1.

  2019

  Habe, K. Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations. Sci Rep. 2019 Feb 5;9(1):1410.

2018

• 6.

  2018

  Ichikawa, A. Pyoderma gangrenosum reproduced by an electric current flow. J Dermal. 2019 Feb;46(2):e64-e66.

• 5.

  2018

  Katayama, H. An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. Clin Appl Thromb Hemost, 2018 Oct;24(7):1170-1176. d

• 4.

  2018

  Kato, S. The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy. J Invest Dermal, 2018 Oct;138(10):2280-2283.

• 3.

  2018

  Kondo, M. Comparison of positive ratio for red meat-specific immunoglobulin E between endemic and non-endemic area for Japanese spotted fever in Mie Prefecture, Japan. J Dermatol,2018 Nov;45(11):e311-e313.

• 2.

  2018

  Kondo, M. Case of Scedosporium aurantiacum infection detected in a subcutaneous abscess. Medical Mycology Case Reports, 2018 Jan 10;20:26-27.

• 1.

  2018

  Tamura, A. Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor. Ann Hematol.2019 Jan;98(1):209-210.

2017

• 19.

  2017

  Amagai, M. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci 85(2): 77-84.

• 18.

  2017

  Gyoubu, M. Long-lasting effect of intra-tumor administration of OK-432 against squamous cell carcinoma metastatic lesion International Journal of Advances In Case Reports.

• 17.

  2017

  Habe, K. The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. Clin Appl Thromb Hemost: 1076029617736382.

• 16.

  2017

  Habe, K. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. Clin Appl Thromb Hemost 23(6): 622-630.

• 15.

  2017

  Imafuku, S. Interleukin-17-mediated manifestation of psoriasis and tinea. Australasian Journal of Dermatology, in press.

• 14.

  2017

  Kakeda, M. Is the Anti-NXP-2(ANTI-MJ) antibody a marker antibody for dysphagia in dermatomyositis?-report of three cases. EMJ Dermatology 5(1): 57-58.

• 13.

  2017

  Kamimoto, Y. Hypofibrinogenemia and the alpha-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. Clin Appl Thromb Hemost 23(1): 52-57.

• 12.

  2017

  Kondo, M. Case of dengue fever missed at the initial screening of an endemic area but developed later in Japan. J Dermatol 44(7): 847-848.

• 11.

  2017

  Kondo, M. Case with cellulitis, lymphangitis and subcutaneous nodule suspected due to Rickettsia japonica carrying tick bite. J Dermatol 44(10): 1182-1183.

• 10.

  2017

  Kondo, M. Rickettsia species among ticks in an area of Japan endemic for Japanese spotted fever. Southeast Asian J Trop Med Public Health 48(3): 585-589.

• 9.

  2017

  Kondo, M. Case with acute urticaria by red meat after Haemaphysalis longicornis bite. J Dermatol 44(7): e168-e169.

• 8.

  2017

  Mizutani, K. Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome. J Dermatol 44(12): 1389-1391.

• 7.

  2017

  Okada, K. Cutaneous polyarteritis nodosa causing refractory skin deformation and pigmentation as sequel. An Bras Dermatol 92(5 Suppl 1): 53-55.

• 6.

  2017

  Okada, K. Well-controlled juvenile dermatomyositis over 20 years recurred after delivery. J Dermatol 44(7): 855-857.

• 5.

  2017

  Sekiya, A. Compound heterozygotes for filaggrin gene mutations do not always show severe atopic dermatitis. J Eur Acad Dermatol Venereol 31(1): 158-162.

• 4.

  2017

  Thomi, R. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol.

• 3.

  2017

  Yamanaka, K. Restrictive IL-10 induction by an innocuous parainfluenza virus vector ameliorates nasal allergy. J Allergy Clin Immunol 139(2): 682-686 e687.

• 2.

  2017

  Yamanaka, K. Skin inflammation leads immunoglobulin G aggregation and deposition in multiple organs. J Dermatol Sci 88(1): 146-148.

• 1.

  2017

  Yamanaka, K. Neutrophils are not the dominant interleukin-17 producer in psoriasis. J Dermatol 44(7): e170-e171.

2016

• 12.

  2016

  Chalmers, J. R. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol 175(1): 69-79.

• 11.

  2016

  Habe, K. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Intern Med 55(6): 589-595.

• 10.

  2016

  Higashiyama, A. Flutamide-induced photoleukomelanoderma. J Dermatol 43(9): 1105-1106.

• 9.

  2016

  Kondo, M. Two Japanese siblings affected with Chikungunya fever with different clinical courses: Imported infections from the Cook Islands. J Dermatol 43(6): 697-700.

• 8.

  2016

  Kondo, M. Case of lumbar disc hernia caused in the left L4 and L5 dermatomes after herpes zoster infection in the right L2 and L3 dermatomes. Journal of Dermatology 43(8): 977-978.

• 7.

  2016

  Kondo, M. First case of redness and erosion at bacillus Calmette-Guerin inoculation site after vaccination against influenza. J Dermatol 43(10): 1229-1231.

• 6.

  2016

  Kondo, M. A case series of mamushi bite and adverse effects of antiserum injection in several cases. Int J Adv Med 3: 1065-1067.

• 5.

  2016

  Kondo, M. Nodules behind the ears: IgG4-related skin disease. Br J Dermatol 175(5): 1056-1058.

• 4.

  2016

  Mitani, O. Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine. J Wound Care 25(9): 521-529.

• 3.

  2016

  Suehara, K. Color Calibration for the Pressure Ulcer Image Acquired Under Different Illumination:A Key Step for Simple,Rapid and Quantitative Color Evaluation of the Human Skin Diseases Using a Digital Camera. Journal of Light&Visual Environment 40: 10-19.

• 2.

  2016

  Umaoka, A. Infantile giant　molluscumcontagiosum:The importance of early intervention. International Journal of Advances In Case Reports 3(7): 94.

• 1.

  2016

  Yamanaka, K. A new biomarker for psoriasis. Br J Dermatol 174(6): 1191-1192.

2015

• 12.

  2015

  Isoda, K. Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin. J Dermatol 42(2): 181-188.

• 11.

  2015

  Isoda, K. Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males. Skin Res Technol 21(2): 247-253.

• 10.

  2015

  Kido-Nakahara, M. Comparative cut-off value setting of pruritus intensity in visual analogue scale and verbal rating scale. Acta Derm Venereol 95(3): 345-346.

• 9.

  2015

  Kondo, M. Biting by ticks carrying rickettsia tamurae is not always risk for rickettsia disease in an immunocompetent subject. International Journal of Advances In Case Reports 2(21): 1271-1273.

• 8.

  2015

  Kondo, M. Improvement in early diagnosis of Japanese spotted fever by using a novel Rick PCR system. J Dermatol 42(11): 1066-1071.

• 7.

  2015

  Kondo, M. A first report of rickettsia japonica detected from amblyomma testudinarium. International Journal Of Advances In Case Reports 2(21): 1268-1270.

• 6.

  2015

  Sasoh, M. Incidence of retinal detachment associated with atopic dermatitis in Japan: review of cases from 1992 to 2011. Clin Ophthalmol 9(9): 1129-1134. Matthews, A. G. Compound heterozygous mutation of Rag1 leading to Omenn syndrome. PLoS One 10(4): e0121489.

• 5.

  2015

  Yamanaka, K. Band-like lipoatrophy on the forearm by injected triamcinolone acetonide to wrist joint. J Dermatol 42(9): 934-935.

• 4.

  2015

  Yamanaka, K. “Inflammatory skin march”: IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events. J Allergy Clin Immunol 136(3): 823-824.

• 3.

  2015

  Yamanaka, K. Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleepquality in atopic dermatitis.Exp Dermatol 24(3): 227-229.

• 2.

  2015

  Yamanaka, K. Pyoderma gangrenosum and annular erythema associated with Sjogren’s syndrome controlled with minocycline. J Dermatol 42(8): 834-836.

• 1.

  2015

  Yamanaka, K. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen. Allergol Int 64(1): 54-59.

2014

• 12.

  2014

  Akeda, T. CD8+ T cell granzyme B activates keratinocyte endogenous IL-18. Arch Dermatol Res 306(2): 125-130.

• 11.

  2014

  Brzezinski, P. DERMATOLOGY EPONYMS-SIGN-LEXICON-(M). Our Dermatol Online3 5(3).

• 10.

  2014

  Chalmers, J. R. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol 171(6): 1318-1325.

• 9.

  2014

  Dohi, K. Arrhythmogenic right ventricular cardiomyopathy in a 20-year-old woman with systemic sclerosis. Intern Med 53(9): 973-977.

• 8.

  2014

  Kakeda, M. Increased expression of heat shock protein 90 in keratinocytes and mast cells in patients with psoriasis. J Am Acad Dermatol 70(4): 683-690 e681.

• 7.

  2014

  Kakeda, M. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis. Arch Dermatol Res 306(10): 933-938.

• 6.

  2014

  Nigi, Y. Pyoderma gangrenosum with corneal perforation by Mooren’s ulcer. J Dermatol 41(5): 466-467.

• 5.

  2014

  Noro, Y. Novel acoustic evaluation system for scratching behavior in itching dermatitis: rapid and accurate analysis for nocturnal scratching of atopic dermatitis patients. J Dermatol 41(3): 233-238.

• 4.

  2014

  Takagi, Y. A new formula for a mild body cleanser: sodium laureth sulphate supplemented with sodium laureth carboxylate and lauryl glucoside. Int J Cosmet Sci 36(4): 305-311.

• 3.

  2014

  Yamanaka, K. Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases. PLoS One 9(8): e104479.

• 2.

  2014

  Yamanaka, K. Continuous high-dose antigen exposure preferentially induces IL-10, but intermittent antigen exposure induces IL-4. Exp Dermatol 23(1): 63-65.

• 1.

  2014

  Yamanaka, K. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils. J Dermatol 41(8): 679-685.

2013

• 7.

  2013

  Habe, K. Two patients with antiphospholipid antibody developed disseminated intravascular coagulation. Intern Med 52(2): 269-272.

• 6.

  2013

  Habe, K. Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. Int J Hematol 97(3): 345-350.

• 5.

  2013

  Imai, Y. Skin-specific expression of ILー33 activates group 2 elicits atopic dermatitisーlike inflammation in mice.Proceedings of the National Academy of Sciences of the United States of America 110(34): 13921-13926.

• 4.

  2013

  Kitagawa, H. Intranasally administered antigen 85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector ameliorates mouse atopic dermatitis. PLoS One 8(7): e66614.

• 3.

  2013

  Lee, H. Y. Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm 2013: 916497.

• 2.

  2013

  Nakanishi, T. Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation. Arch Dermatol Res 305(3): 241-247.

• 1.

  2013

  Sugiura, K. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 133(11): 2514-2521.

2012

• 9.

  2012

  Akeda, T. Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon-gamma and tumour necrosis factor-alpha. Clin Exp Dermatol 37(2): 193-194.

• 8.

  2012

  Habe, K. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. Thromb Res 129(5): 598-602.

• 7.

  2012

  Kakeda, M. Heat-killed bacillus Calmette-Guerin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells. Br J Dermatol 166(5): 953-963.

• 6.

  2012

  Konishi, Y. Treatment of vitiligo vulgaris with the combination therapy of topical steroid and vitamin D3 compound. Dermatol Reports 4(1): e8.

• 5.

  2012

  Mizutani, H. Single step modified ink staining for Tzanck test: quick detection of herpetic giant cells in Tzanck smear. J Dermatol 39(2): 138-140.

• 4.

  2012

  Nakamori, R. Complete remission of advanced extramammary Paget’s disease treated with docetaxel: a case report. Clin Exp Dermatol 37(2): 194-195.

• 3.

  2012

  Tsuda, K. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells. PLoS One 7(2): e31465.

• 2.

  2012

  Tsuda, K. Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity. PLoS One 7(12): e51819.

• 1.

  2012

  Yuta A. Therapeutic outcomes and immunological effects of sublingual immunotherapy for Japanese cedar pollinosis Clinical & Experimental Allergy Reviews 12: 29-35.

2011

• 11.

  2011

  Clark, R. A. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Blood 117(6): 1966-1976.

• 10.

  2011

  Isoda, K. Treatment of cloth with a fabric softener ameliorates skin dryness. J Dermatol 38(7): 685-692.

• 9.

  2011

  Kitagawa, H. Propionibacterium acnes vaccination induces regulatory T cells and Th1 immune responses and improves mouse atopic dermatitis. Exp Dermatol 20(2): 157-158.

• 8.

  2011

  Kondo, M. Sarcoidosis with both plaque and subucutaneus nodules associated with combination therapy with peginterferon α-2a and ribavirin. Case reports in Dermatological Medicine

• 7.

  2011

  Kurokawa, I. Expression of keratins in cutaneous epithelial tumors and related disorders- distribution and clinical significance. Exp Dermatol 20(3): 217-228.

• 6.

  2011

  Kurokawa, I. Keratin and filaggrin expression in comedonal Darier’s disease. J Dermatol 38(11): 1089-1092.

• 5.

  2011

  Oiso, N. The histopathological feature of the nail isthmus in an ectopic nail. Am J Dermatopathol 33(8): 841-844.

• 4.

  2011

  Tsuda, K. Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses. PLoS One 6(12): e29020.

• 3.

  2011

  Tsutsui, H. Contribution of interleukin 18 to the development of infection-associated atopic dermatitis. Curr Probl Dermatol 41: 93-103.

• 2.

  2011

  Yamanaka, K. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol 41: 80-92.

• 1.

  2011

  Yamanaka, K. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes approximately IL-10 productivity is critical for becoming allergic approximately. Allergol Int 60(1): 45-51.

2010

• 13.

  2010

  Kondo, M. Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus? Int J Dermatol 49(12): 1403-1405.

• 12.

  2010

  Kondo, M. Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever. Journal of Dermatology 37(9): 835-836.

• 11.

  2010

  Kondo, M. Nine cases of Japan spotted fever diagnosed at our hospital in 2008. International Journal of Dermatology 49(4): 430-434.

• 10.

  2010

  Konishi, H. Possible case for false-positive reaction in serum 5-S-cysteinyldopa levels in a patient with malignant melanoma by ingestion of Agaricus blazei Murrill extract. J Dermatol 37(8): 773-775.

• 9.

  2010

  Kurokawa, I. Immunohistochemical study of cytokeratin expression in nevus sebaceous. Int J Dermatol 49(4): 402-405.

• 8.

  2010

  Omoto, Y. Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci 59(2): 129-135.

• 7.

  2010

  Senba, Y. Primary cutaneous apocrine carcinoma arising within a congenital nevus: Keratins and filaggrin expression suggesting differentiation into the secretory cells of apocrine glands. Oncology Letters 1(3): 413-416.

• 6.

  2010

  Tsuji, N. Epidermal cyst with pilomatricoma (follicular hybrid cyst): immunohistochemical study with epithelial keratins and filaggrin. J Dermatol 37(10): 922-925.

• 5.

  2010

  Tsuruta, D. Three-base deletion mutation c.120_122delGTT in ATP2A2 leads to the unique phenotype of comedonal Darier disease. Br J Dermatol 162(3): 687-689.

• 4.

  2010

  Tsuruta, D. Letter: Adult measles with a butterfly rash-like appearance. Dermatol Online J 16(3): 16.

• 3.

  2010

  Yamanaka, K. Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma. Arch Dermatol Res 302(6): 453-459.

• 2.

  2010

  Yamanaka, K. I. 1,24-Dihydroxyvitamin D(3) (tacalcitol) prevents skin T-cell infiltration. Br J Dermatol 162(6): 1206-1215.

• 1.

  2010

  Yoshida, M. A Case of Multiple Pilosebaceous Cysts. Case Rep Dermatol 2(2): 116-119.

2009

• 12.

  2009

  Fujimoto, T. Cutaneous malignant fibrous histiocytoma (undifferentiated pleomorphic sarcoma) arising in a chronic scalp ulcer of a patient with non-bullous congenital ichthyosiform erythroderma. J Eur Acad Dermatol Venereol 23(2): 202-203.

• 11.

  2009

  Iinuma, K. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 129(9): 2113-2119.

• 10.

  2009

  Kondo, M. Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. Int J Dermatol 48(12): 1330-1333.

• 9.

  2009

  Kurokawa, I. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology 18(10): 821-832.

• 8.

  2009

  Kurokawa, I. Pilomatricoma can differentiate not only towards hair matrix and hair cortex,but also follicular infundibulum,outer root sheath and hair bulge. Experimental Dermatology 18(8): 734-737.

• 7.

  2009

  Mori, H. Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. Archives of Dermatological Research 301(2): 151-157.

• 6.

  2009

  Morioka, T. A case of beau’s lines at even intervals and onycholysis caused by chemotherapy. The Open Dermatology Journal 3(1): 16-17.

• 5.

  2009

  Morioka, T. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis. Br J Dermatol 160(6): 1172-1179.

• 4.

  2009

  Senba, Y. Folliculosebaceous cystic hamartoma differentiates toward the infundibulum, sebaceous duct and sebaceous cells: immunohistochemical study of keratins and filaggrin. Br J Dermatol 160(2): 454-456.

• 3.

  2009

  Senba, Y. Case of creeping disease treated with ivermectin. J Dermatol 36(2): 86-89.

• 2.

  2009

  Sugisaki, H. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 55(1): 47-52.

• 1.

  2009

  Yamanaka, K. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis. J Allergy Clin Immunol 124(4): 842-845 e847.

2008

• 14.

  2008

  Imai, Y. Freshly isolated Langerhans cells negatively regulate naive T cell activation in response to peptide antigen through cell-to-cell contact. J Dermatol Sci 51(1): 19-29.

• 13.

  2008

  Ito, Y. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. BMB Rep 41(2): 139-145.

• 12.

  2008

  Ito, Y. Keratin and filaggrin expression in keratoacanthoma. J Eur Acad Dermatol Venereol 22(3): 353-355.

• 11.

  2008

  Ito, Y. Necrobiotic xanthogranuloma with paraproteinemia; an atypical case. J Dtsch Dermatol Ges 6(1): 40-43.

• 10.

  2008

  Kakudo, N. Dumbbell-formed lipomas under the zygomatic arch. J Plast Reconstr Aesthet Surg 61(1): 107-110.

• 9.

  2008

  Kurzen, H. What causes hidradenitis suppurativa? Experimental Dermatology 17(5): 455-472.

• 8.

  2008

  Nakagawa, N. Adult cutaneous alveolar rhabdomyosarcoma on the face diagnosed by the expression of PAX3-FKHR gene fusion transcripts. J Dermatol 35(7): 462-467.

• 7.

  2008

  Nakaminami, H. Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 60(2): 108-117.

• 6.

  2008

  Sugimura, Y. Identification of preferred substrate sequences for transglutaminase 1-development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin. Febs Journal 275(22): 5667-5677.

• 5.

  2008

  Takagi, E. Clinical and histopathological features in Henoch-Schonlein purpura. Int J Dermatol 47(1): 48-49.

• 4.

  2008

  Tokime, K. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model. Arch Dermatol Res 300(7): 343-352.

• 3.

  2008

  Tsuda, T. Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. Antimicrob Agents Chemother 52(4): 1538-1541.

• 2.

  2008

  Tsuda, T. A novel point mutation of keratin 17 (KRT17) in a Japanese family with pachyonychia congenita type 2: an RNA-based genetic analysis using a single hair bulb. British Journal of Dermatology 159(3): 730-732.

• 1.

  2008

  Yamanaka, K. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol 121(1): 148-157 e143.

2007

• 12.

  2007

  Ito, Y. Magnetic resonance (MR) imaging-induced deep second-degree burns of lower extremities by conducting loop. J Eur Acad Dermatol Venereol 21(8): 1140-1141.

• 11.

  2007

  Kitagawa, H. Cutaneous horn can be a clinical manifestation of underlying sebaceous carcinoma. British Journal of Dermatology 156(1): 180-182.

• 10.

  2007

  Kurokawa, I. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster. Int J Clin Pract 61(7): 1223-1229.

• 9.

  2007

  Kurokawa, I. Cytokeratin and filaggrin expression in nevus comedonicus. J Cutan Pathol 34(4): 338-341.

• 8.

  2007

  Kurokawa, I. Rippled-pattern sebaceoma with an immunohistochemical study of cytokeratins. J Eur Acad Dermatol Venereol 21(1): 133-134.

• 7.

  2007

  Kurokawa, I. Eccrine spiradenoma: co-expression of cytokeratin and smooth muscle actin suggesting differentiation toward myoepithelial cells. J Eur Acad Dermatol Venereol 21(1): 121-123.

• 6.

  2007

  Kurokawa, I. Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol 34(9): 675-678.

• 5.

  2007

  Kurokawa, I. Filaggrin expression and the pathogenesis of epidermal cysts. Br J Dermatol 157(2): 415-416.

• 4.

  2007

  Kurokawa, I. Pinkus tumor may originate from intraepidermal eccrine ducts and proliferate in the dermis. Oncology Reports 17(1): 49-54.

• 3.

  2007

  Nakaminami, H. Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. Biol Pharm Bull 30(8): 1412-1415.

• 2.

  2007

  Shima, S. A case of Admantiades-Behcet disease with ischemic optic neuritis (posterior optic neuropathy). JDDG 5: 1010-1014.

• 1.

  2007

  Yokoyama, T. Pilonidal sinus of the supra-auricle area. J Eur Acad Dermatol Venereol 21(2): 257-258.

2006

• 16.

  2006

  Clark, R. A. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176(7): 4431-4439.

• 15.

  2006

  Clark, R. A. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126(5): 1059-1070.

• 14.

  2006

  Hirahara, K. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 177(7): 4488-4494.

• 13.

  2006

  Kurokawa, I. Cytokeratin, filaggrin, and p63 expression in reepithelialization during human cutaneous wound healing. Wound Repair Regen 14(1): 38-45.

• 12.

  2006

  Kurokawa, I. Cutaneous dermoid cyst: cytokeratin and filaggrin expression suggesting differentiation towards follicular infundibulum and mature sebaceous gland. Oncol Rep 16(2): 295-299.

• 11.

  2006

  Kurokawa, I. Cytokeratin expression in subungual squamous cell carcinoma. J Int Med Res 34(4): 441-443.

• 10.

  2006

  Kurokawa, I. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum. In Vivo 20(5): 583-585.

• 9.

  2006

  Kurokawa, I. Keratin profiles may differ between intraepidermal and intradermal invasive eccrine porocarcinoma. Oncol Rep 16(3): 473-478.

• 8.

  2006

  Murakami, T. Topical suplatast tosilateÅiIPDÅjameliorates Th2 cytokine-mediated dermatitis of caspase-1 transgenic mouse by downregulating interleukin-4 and interleukin-5. British Journal Dermatol 155(1): 27-32.

• 7.

  2006

  Nishimura, K. Reduced Heterochromatin protein 1-beta(HP1É¿) expression is correlated with increased invasive activity in human melanoma cells. ANTICANCER RESEARCH 26: 4349-4356.

• 6.

  2006

  Noguchi, N. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J Clin Microbiol 44(6): 2119-2125.

• 5.

  2006

  Omoto, Y. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J Immunol 177(12): 8315-8319.

• 4.

  2006

  Terada, M. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci U S A 103(23): 8816-8821.

• 3.

  2006

  Umeda, K. A novel acoustic evaluation system of scratching in mouse dermatitis: rapid and specific detection of invisibly rapid scratch in an atopic dermatitis model mouse. Life Sci 79(22): 2144-2150.

• 2.

  2006

  Yamanaka, K. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Clin Cancer Res 12(2): 376-382.

• 1.

  2006

  Yamanaka, K. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood 107(6): 2440-2445.

2005

• 20.

  2005

  Clark, R. Human skin cells support thymus-independent T cell development. J Clin Inves 115(11): 3239.

• 19.

  2005

  Inaba, T. Complete remission in a patient with angiosarcoma by the combination of OK-432,rhIL-2,and radiotherapy. Eur J Dermatol 15(5): 411-413.

• 18.

  2005

  Ishii, A. A Case of epidermotropic metastatic malignant melanoma with multiple nodular lesions of the scalp. The Journal of Dermatology 32(10): 821-826.

• 17.

  2005

  Jones, D. Activation of neutrophils in cutaneous T cell lymphoma. Clin Cancer Res.

• 16.

  2005

  Kakeda, M. A Case of Histopathologically Typical Toxic Epidermal Necrolysis Despite No Visible Blisters or Erosive Lesions. Journal of Dermatology 32(8): 654-660.

• 15.

  2005

  Yamanaka, K. Expression of interleukin-18 and caspase-1 in cutaneous T cell lymphoma.Journal of Investigative Dermatology 124(4): A47-A47.

• 14.

  2005

  Kurokawa, I. Purpuric drug eruption possibly due to gefinitib(Iressa). Int J Dermatol 44(2): 167-168.

• 13.

  2005

  Kurokawa, I. Keratinizing squamous epithelium associated with Syringocystoadenoma papilliferum differentiates towards infrainfundibulum: case report with immunohistochemical study of cytokeratins. The Journal of International Medical Research 33: 590-593. 14. Kurokawa, I. Trichoadenoma:cytokeratin expression suggesting differentiation towards the follicular infundibulum and follicular bulge regions. British Journal of Dermatology 153(5): 1084-1086.

• 12.

  2005

  Kurokawa, I. A case report of hidroacanthoma simplex with an immnnohistochemical study of cytokeratins. Int J Dermatol 44(9): 775-776.

• 11.

  2005

  Kurokawa, I. Vesicular drug eruption due to Stronger Neo-minophagen C. Int J Dermatol 44(10): 881-882.

• 10.

  2005

  Kurokawa, I. Exacerbation of palmoplantar pustulosis by granulocyte colony-stimulating factor. Int J Dermatol 44(6): 529-530.

• 9.

  2005

  Kurokawa, I. Lichen planus-type drug eruption resulting from ticlopidine. Int J Dermatol 44(5): 436-437.

• 8.

  2005

  Mori, H. Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer. J Dermatol 32(4): 290-294.

• 7.

  2005

  Nakanishi, A. Atelocollagen sponge and recombinant basic fibroblast growth factor combination therapy for resistant wounds with deep cavities. The Journal of Dermatology 32(5): 376-380.

• 6.

  2005

  Nishizawa, M. Identification of Trichoplein,a novel keratin filament-binding protein. Journal of Cell Science 118(5): 1081-1090.

• 5.

  2005

  Nomura, E. Extra Nodal NK/T-Cell Lymphoma Nasal Type that Responded to DeVIC Combination Chemotherapy. Journal of Dermatology 32(3): 204-209.

• 4.

  2005

  Shen, C. The Expression of p63 during Epidermal Remodeling in Psoriasis. Journal of Dermatology 32(4): 236-242.

• 3.

  2005

  Yamaguchi, T. Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis. J Cell Biol 171(3): 431-436.

• 2.

  2005

  Yamanaka, K. Basic fibroblast growth factor treatment for skin ulceration associated with systemic sclerosis dominant overlap syndrome. Cutis.

• 1.

  2005

  Yokoyama, T. Aurora-B and Rho-kinase/Rock,the two cleavage furrow kinases,independently regulate the progression of cytokinesis:Possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin(ERM). Genes Cells 10(2): 127-137.

2004

• 7.

  2004

  Imai, Y. A Case of a Large Dermatofibrosarcoma Protuberans Successfully Treated with Radiofrequency Ablation and Transcatheter Arterial Embolization. Journal of Dermatology 31(1): 42-46.

• 6.

  2004

  Mizutani, H. Animal Models of Atopic Dermatitis. 47 11: 501-507.

• 5.

  2004

  Mori, H. Drug Eruption Caused by Azathioprine:Value of Using the Drug-Induced Lymphocytes Stimulation Test for Diagnosis. Journal of Dermatolory 31(9): 731-736.

• 4.

  2004

  Tsutsui, H. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunological Reviews 202: 115-138.

• 3.

  2004

  Umehara, M. Primary cutaneous anaplastic large cell lymphoma successfully treated by resective operation and postoperative electron-beam therapy. Skin Research 3(5): 493.

• 2.

  2004

  Umehara, M. Disseminated maculo-papular erythematous-type drug eruption due to tipepidine hibenzate. Skin Research 4(2): 121.

• 1.

  2004

  Yamanishi, Y. Apoptopsis in the Epidermis. Molecular Biology 289: 171-174.

2003

• 5.

  2003

  Imai, Y. Primary Cutaneous Follicle Cencer Cell Lymphoma of the Scalp Successfully Treated with Anti CD20 Monoclonal Antibody and CHOP Combination Therapy with No Subsequent Permanent Loss of Hair. Journal of Dermatology 30(9): 683-688.

• 4.

  2003

  Matsushima, M. Bilateral Scalp Necrosis with Giant Cell Arteritis. Journal of Dermatology 30(3): 210-215.

• 3.

  2003

  Mizutani, H. Animal models of psoriasis and pustular psoriasis. Arch Dermtol Res 295: S67-S68.

• 2.

  2003

  Nakano, H. Persistent secretion of IL-18 in the skin contributes to IgE response in mice. Int Immunol 15: 611-621.

• 1.

  2003

  Yawalkar, N. Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 102(12): 4059-4066.

2002

• 2.

  2002

  Konishi, H. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A 99(17): 11340-11345.

• 1.

  2002

  Matsubara, K. Pyoderma gangrenosum associated with paroxysmal nocturnal hemoglobulinuria and monoclonal gammopathy. J Dermatol 29(2): 86-90.

2001

• 1.

  2001

  Sayama, K. Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation. Journal of Biological Chemistry 276(2): 999-1004.

2000

• 5.

  2000

  Mizutani, H. Cassiopeia flap: modification of Limberg flap for saving normal skin. J Dermatol 27(3): 217-219.

• 4.

  2000

  Onoda, K. Atopic dermatitis as a risk factor for acute native valve endocarditis. Journal of Heart Valve Disease 9(3): 469-471.

• 3.

  2000

  Tokime, K. A case of acute graft-versus-host disease following autologous peripheral blood stem cell transplantation. J Dermatol 27(7): 446-449.

• 2.

  2000

  Yamanaka, K. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. Journal of Immunology 165(2): 997-1003.

• 1.

  2000

  Yoshimoto, T. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 1(2): 132-137.